Rizzo et al (22) determined that interference RNA or specific secretion enzyme inhibitors could be used to markedly reduce Notch1 activation and effectively enhance the sensitivity of breast cancer cells to tamoxifen. The gene discussed is NOTCH1; the disease is breast cancer.